Last fall, the World Health Organization (WHO) published the latest global report on tuberculosis (TB). It provides a comprehensive and up-to-date assessment of the TB epidemic and of the progress made in TB prevention, care and control at global, regional and country level, using data reported by 197 countries and territories that account collectively for over 99% of the TB cases in the world.
On page 92, the MAMTS-TB-01 trial from the PanACEA Consortium is mentioned in the chapter about new regimens in phase II trials.
For more information, please see http://www.who.int/tb/publications/global_report/en/.